Compare Citius Pharmaceuticals Inc (CTXR) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Enveric Biosciences Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.71 (market cap $20.01M), while Enveric Biosciences Inc trades at $1.56 (market cap $6.20M). The key difference: Citius Pharmaceuticals Inc is far larger — about 3.2× Enveric Biosciences Inc's market cap, and Citius Pharmaceuticals Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | ENVB | |
|---|---|---|
Market Cap | $20.01M | $6.20M |
Sector | Health | Health |
52-Week High | $1.82 | $17.40 |
52-Week Low | $0.48 | $1.27 |
Enterprise Value | $16.23M | $1.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
